Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI in Subjects With Dry Eye Disease.
NCT04362670
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
OTX-CSI
OTHER:
Placebo Vehicle
Sponsor
Ocular Therapeutix, Inc.